Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3641820 Title: COMPOSITIONS COMPRENANT UN MÉDICAMENT ANTI-INFLAMMATOIRE ET UN ACTIVATEUR DICER DESTINÉES À ÊTRE UTILISÉES DANS LE TRAITEMENT DE MALADIES NEURONALES

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
187532569
WO application number:
IL2018050684
Type:
European patent granted for BE
Status:
Open
Publication number:
3641820
WO publication number:
WO2018235082
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
20/06/2018
Grant date:
28/12/2022
EP publication date:
29/04/2020
WO publication date:
27/12/2018
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
28/12/2022
EP B1 publication date:
28/12/2022
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
20/06/2038

Applicant

Name:
Neurosense Therapeutics Ltd.
Legal Form:
From:
28/12/2022
Address:
85 Medinat Hayehudim, 4676670 Herzeliya, Israel (IL)
To:

Agent

Name:
JUNGHANS Claas
Legal Form:
From:
25/01/2023
Address:
Großbeerenstraße 71, D-10963, BERLIN, Germany (DE)
To:

Inventor

Name:
BEN-NOON, Alon
Legal Form:
Address:
4720807 Ramat HaSharon, Israel (IL)

Priority

Priority patent number:
201762522157 P
Priority date:
20/06/2017
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 31/415; A61K 31/47; A61K 31/496; A61K 45/06; A61P 25/00; A61P 25/16; A61P 25/14; A61P 25/28; A61P 27/02;

Publication

Bulletin

Bulletin heading:
EP2
Journal edition number:
2022/24
Publication date:
20/01/2023
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

European Patent Bulletin

Issue number:
202252
Publication date:
28/12/2022
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
30/06/2025
Annual fee number:
8
Annual fee amount:
135 Euro
Expected payer:
Last annual fee payment date:
20/06/2024
Last annual fee paid number:
7
Last annual fee paid amount:
110 Euro
Payer:
AZAMI GLOBAL(vroeger:International Renewals Group)
Filing date Document type Publication Type Document Description Number of pages File Type
25/01/2023 Incoming Correspondence (Post) 1 PDF /5/1/6/6/7/0722276615/docs/187532569_0_incomingcorrespondencepaper_20230125_015612987.pdf